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Abstract
Background and aims Posterior approach pancreatoduode-
nectomy (paPD) technique is one of the many modifica-
tions of the standard Whipple procedure (sPD). The most
important modification of the technique is first approach of
the superior mesenteric artery, thus enabling a complete
dissection of the right side of this artery and of the portal
vein, as well as a complete excision of the retroportal
pancreatic lamina. The present study is a case-match one,
comparing the paPD to sPD.
Materials and methods The present study includes two
groups of patients. A first group of 21 patients with PD by
posterior approach (group 1, reference group, paPD) and a
second group including 21 matched patients with PD by
standard approach (group 2, control group, sPD). Demographic
characteristics (sex, age), intraoperative data (approach type,
operative time, blood loss, intraoperative complications, need
for vascular resections and type of reconstruction, type of
resection upon remnant tissue), histological diagnosis and
pathology data (tumor location, TNM staging, tumor grading,
tumor vascular invasion), patient outcomes (postoperative
length of stay, in-hospital postoperative mortality and morbid-
ity, survival time) were analyzed in both groups of patients and
compared.
Results There were no significant differences in the two
groups regarding early morbidity and mortality rates, length
of hospitalization, overall survival, and survival according
to tumor type. However, it was noticed that there was a
significant lesser mean blood loss in the pa PD group vs
SPD group (P=0.0314) and a shorter operative time in the
paPD group vs sPD group (P=0.0002).
Conclusion The paPD offers an early selection of patients
during the operation (in terms of local resectability, by
assessing the SMA infiltration), allows an optimal exposure
of arterial abnormalities (a replaced right hepatic artery
from the SMA), and better detection of venous invasion. In
cases with PV/SMV invasion, paPD is particularly useful
allowing a “no-touch” resection with no intraportal tumor
dissemination and facilitates the vascular reconstruction. In
addition, the operative bleeding and time are lower in the
paPD group, probably due to early ligation of the inferior
pancreaticoduodenal artery and reduced congestion of the
pancreatic head.
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Introduction
Pancreaticoduodenectomy (PD) is considered a complex
operative technique, being recommended as the procedure
of choice in surgical treatment of periampullary and
pancreatic head tumors. PD is particularly indicated for
malignant tumors (pancreas head carcinoma, malignancies of
the Vater’s ampulla and distal common bile duct, duodenal
cancer), as the single hope for cure of these patients.
Nowadays, the PD is more rarely used in the management
of benign lesions; in these cases, a conservative resection is
recommended when possible [1–3].
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technique of the PD, this operative procedure became
widely known, and many modifications and improvements
of the original Whipple’s procedure have been made [4–9].
Posterior approach for PD (paPD) is one of the many
modifications of standard PD (sPD), and the procedure is
focused on the early dissection of the posterior pancreatic
capsule and first dissection of the superior mesenteric artery
(SMA). The posterior part of the pancreatic head is
dissected off the mesenteric vessels without dividing the
pancreatic neck, thus the surgeon may avoid the “point of
no return” of standard procedure and early identification of
nonresectability (i.e., SMA tumor involvement). By poste-
rior approach, a replaced right hepatic artery can be easily
detected, and associated en bloc resection of the portal vein
(PV)/superior mesenteric vein (SMV) is facilitated, using
the “no-touch” technique [10–12].
There are several reports describing the operative
technique of the paPD (called posterior approach, SMA
first approach, etc.), but there is no paper presenting a
comparative study between the paPD and sPD [10–12].
We previously described our technical version of paPD,
focusing on specific and technical issues of the operation
and analyzing the preliminary results for the first selected
patients [12].
The aim of this paper is top r e s e n tac a s e - m a t c h
retrospective study comparing patients undergoing either
paPD or sPD. The intraoperative data and postoperative
outcome (including long-term survival) were compared in
the two groups of patients.
Materials and methods
Patients
Between January 2003 and April 2007, 218 consecutive
patients underwent PD for periampullary tumors and
pancreatic head cancer at the Centre of General Surgery
and Liver Transplantation, Fundeni Clinical Institute. Thus,
the average number of PD per year was 51, corresponding
to a high volume centre [13–15]. Of these 218 patients, a
matched group of 21 patients was selected.
The present study includes two groups of patients. A
first group of 21 patients with PD by posterior approach
(group 1, reference group, paPD) and a second group
including 21 matched patients with PD by standard
approach (group 2, control group, sPD). Patient selection
into the reference group was done due to the preference of
the senior surgeon (I. Popescu) for this type of approach;
patients from the control group were selected from sPD
performed either by the senior surgeon (I. Popescu) or by
surgeons with the same expertise in performing sPD. The
expertise in sPD is higher than in paPD. The percentage of
paPD out of 218 PD was 9.63%.
Patient’s data were obtained by retrospective review
from a prospectively gathered database at the Centre of
General Surgery and Liver Transplantation of Fundeni
Clinical Institute.
The matching variables were age, sex, location and type
of the tumor, associated vascular resections, and follow-up
time from surgery. Age and sex are usual matching
variables, location of the tumor is considered to be highly
important in survival studies, associated vascular resections
sum up to the advanced stage of the disease, and time from
surgery is selected in order to obtain similar follow-up
intervals for the two groups. Assessment in cases with PV/
SMV invasion was done preoperatively by dynamic
contrast-enhanced computed tomography and confirmed
by intraoperative exploration. The follow-up was complete
for all patients, the duration of follow-up being similar in
both groups (range, 19 to 45 months). As shown in Table 1,
age, sex, location and type of the tumor, number of vascular
resections in each group are similar in the two groups.
Demographic characteristics (sex, age), intraoperative
data (approach type, operative time, blood loss, intra-
operative complications, need for vascular resections and
type of reconstruction, type of resection upon remnant
Factor Group 1 (paPD) Group 2 (sPD) P value
Age (years) 56 (±14.88) 59.19 (±7.99) 0.3918, NS
Sex
Male 9 9 1, NS
Female 12 12
Tumour location
Pancreatic head 11 11 1, NS
Ampulloma 6 6 1, NS
Distal choledocus 3 4 1, NS
Duodenum 1 0 1, NS
Vascular resection and reconstruction (PV/SMV) 3 3 1, NS
Table 1 Distribution of
the matching variables in the
two groups
NS not significant
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location, TNM staging, tumor grading, tumor vascular
invasion), patients outcomes (postoperative length of stay,
in-hospital postoperative mortality and morbidity, survival
t i m e )w e r ea n a l y z e di nb o t hg r o u p so fp a t i e n t sa n d
compared.
Surgical technique
Standard technique of PD (sPD) is quite similar in most of the
surgical centers and was described elsewhere [1, 3, 4, 6, 7].
Briefly, after the incision is made, the abdominal cavity is
carefully explored in order to establish the presence of liver or
peritoneal metastasis (these findings preclude any resection).
In sPD, the approach to determine local resectability begins
by mobilizing the right colon from the right upper quadrant.
After that, the Kocher’s maneuver is performed, and the third
and fourth part of the duodenum is reflected, the pancreas
being elevated so that a hand can be passed behind the
pancreas to palpate the tumor mass. Thus, this maneuver can
usually determine the tumor involvement of the SMA
(resulting in ending of the procedure and conversion to a
palliative surgery) or PV/SMV invasion (resulting in
performing vascular resection and reconstruction). If the
SMA is not involved, the lesser sac is then entered;
the anterior surface of the SMV is identified. After dividing
the right gastroepiploic vein, anterior branch of the inferior
pancreaticoduodenal vein and middle colic vein (the last one
only when strictly necessary), the anterior surface of the SMV
and then PV is carefully dissected from the posterior part of
the pancreatic neck. The common hepatic artery is then
carefully dissected, and the gastroduodenal artery is identified,
ligated, and divided. The cholecystectomy is performed, and
after that, the common bile duct is ligated and divided. The
PV can be now dissected free from the pancreas at its superior
edge. Depending on the type of procedure (Whipple or
pylorus preserving PD), the stomach or the duodenum is
transected. After complete detachment of the PV from the
posterior surface of the pancreatic neck, the transection of the
pancreas is made. The pancreatic head along with distal
common bile duct, duodenum (± distal stomach), and first
jejunal loop (after mobilization of Treitz’s angle) is dissected
from the right side of the PV and SMV, and the operative
specimen is removed. If the tumor is adherent or invades the
PV/SMV, a resection may be needed with vascular recon-
struction (with or without graft interposition, depending on
local situation).
The technique of paPD was described elsewhere [10–12].
Briefly, an extensive Kocher’s maneuver is made (up to the
level of the left border of the aorta), followed by mobiliza-
tion of the third duodenum to the proximity of the
duodenojejunal flexure, beneath the superior mesenteric
vessels and the mesentery, by mobilizing the right colon,
right colic flexure, and the right portion of the transverse
mesocolon. Extensive “Kocherization” allows a good expo-
sure of the aortocaval region; the presence of enlarged
lymphadenopathy reported as positive by frozen section
examination preclude any curative resection. After complete
mobilization of the pancreatic head, in the angle between the
left border of the inferior vena cava and the superior border
of the left renal vein, the origin of SMA is identified. The
whole lymphatic tissue originating at this level (representing
the left portion of the retroportal process) is divided by a
step-by-step procedure. Using a vascular tape around the
SMA, subsequently, the artery is separated from the
pancreatic tissue and PV, and the inferior and posterior
pancreaticoduodenal arteries are divided. The lymph nodes
and the lymphatic tissue between the PV and SMA are
dissected. Whenever a replaced right hepatic artery originat-
ing from the SMA is found, the artery should be dissected
and carefully protected. After reflection of the duodenum
and first jejunal loop beneath the mesenteric vessels, the first
jejunal arteries can be firstly divided. This surgical step is
followed by complete separation of SMA from the right
retroportal process; the SMA is therefore set free until its
entry into the mesentery. This step of operation is very
important because during this stage, the tumor involvement
to the SMA can be identified (and thus preclude any
resection). Further dissection in this area is performed after
dissection of the hepatoduodenal ligament. The next step is
dissection of the hepatoduodenal ligament with exposure of
the PV. The PV is traced down to the level of the pancreatic
neck by ligating and dividing the surrounding tissues; this
completely exposes the suprapancreatic PV. The dissection
of the PV is continued down by inferomedial traction of the
duodenum and pancreatic head. The posterolateral side of the
PV is carefully dissected, ligating the tributaries. Since there
is an avascular plane between the PV and pancreatic neck,
after this dissection, the posterior surface of the pancreatic
neck is exposed. In case of venous invasion, the PVor SMV
might be resected in accordance with invasion extent: tumors
that involve less than one third of the total circumference
may be resected tangentially and those with more extensive
involvement may be segmentally resected with vascular
reconstruction (with primary anastomosis or graft interposi-
tion). In case of PV invasion, both sides of the vein (up and
down to the tumor involvement) are “looped” for proximal
and distal control. In contrast with sPD, after transection of
the pancreatic neck, the pancreas is at last free from the right
retroportal process.
Reconstructions after resection (anastomosis of the
pancreas, bile duct, and stomach/duodenum to the ascending
jejunum) were made similarly in both techniques. In the
present series, the anastomosis of the pancreas to the jejunum
was first performed. In cases with enlarged Wirsung and
fibrous remnant pancreas, a duct-to-mucosa anastomosis was
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remnant pancreatic tissue and small diameter of the Wirsung,
the whole pancreatic stump was implanted into the jejunum
using interrupted sutures. After that, the choledocus was
implanted into the jejunum using continuous suture. Depend-
ing on the type of operation (Whipple or pylorus preserving
PD),thestomachorthe duodenumwassuturedtothejejunum
by continuous suture.
Statistical analysis
Data were expressed as mean±standard deviation (SD),
unless indicated otherwise. Minimum and maximum values
were provided when necessary. Komolgornov–Smirnov test
was used to assess the distribution of the data. Comparison
of continuous variables was performed using unpaired
Student’s t test and, comparison of categorical variables
was performed using Fisher’s exact test. Survival was
assessed using Kaplan–Meier method. The survival curves
were compared by a log-rank test. A P value less than 0.05
was considered statistically significant.
Results
Intraoperative data
In the group of paPD, the Whipple procedure was
performed in 16 patients and pylorus preserving PD in five
patients; in the sPD group, Whipple procedure was
performed in 14 patients and pylorus preserving PD in
seven patients (P=0.7337,NS).
Venous vascular involvement was recorded in three patients
in both groups (P=1, NS). In the paPD group, there were two
patients with SMV involvement and one patient with PV
trunk invasion; in all cases, the venous resection was followed
by reconstruction using Goretex® graft interposition. In the
sPD group, all the three patients had PV involvement; in two
patients, the resection was followed by primary end-to-end
anastomosis, and in one patient, the reconstruction was done
using a Goretex® graft interposition.
The mean operative time was shorter in the paPD group
vs sPD group. Thus, in the paPD group, the mean operative
time was 228.57 min (±75.78; range, 120 to 450 min), in
comparison with the sPD where the mean operative time was
332.38 min (±85.84; range, 180 to 510 min) (P=0.0002).
The mean blood loss was also lesser in the paPD group
vs sPD group. Thus, in the paPD group, the mean blood
loss was 292.86 ml (±195.12; range, 100 to 1000 ml), in
comparison with the sPD where mean blood loss was
435.71 ml (±219.17; range, 200 to 1000 ml) (P=0.0314).
In both groups, there was no significant intraoperative
incident.
Pathology data
There are no significant differences in the two groups
regarding the tumor type and location, TNM status and
staging, grade of differentiation, and tumor vascular
invasion. It is also underlined the fact that in both groups,
there are the same number of patients with no residual
tumor type of resection (R0) and with microscopically
residual tumor (R1; 12 vs nine patients, P=1, NS). These
data are very important for the impact on the long-term
survival of the patients in the two groups. Thus, having the
same well-known prognostic factors influencing the long-
term survival in both groups, we can establish the impact of
the type of approach (paPD vs sPD) on the long-term
survival of the patients.
Early mortality and morbidity
Early mortality and morbidity rates were defined as
in-hospital mortality and morbidity.
There were no postoperative deaths in both groups.
Postoperative complications were encountered in seven
patients with paPD (33.33%). Pancreatic fistula was defined
according to the International Study Group of Pancreatic
Fistula [16]. In the paPD group, pancreatic fistula was
encountered in five patients: one patient grade A fistula and
grade B in four patients (all conservatively managed). Other
complications were: hemoperitoneum from pancreatic
stump imposing reintervention for hemostasis in one patient,
followed by pancreatic fistula; one patient developed
postoperative upper digestive hemorrhage conservatively
treated, followed by bronchopneumonia—treated with
antibiotics; one patient presented graft thrombosis and
imposed reintervention for dethrombosing in the first
postoperative day.
Postoperative complications were encountered in nine
patients with sPD (42.85%). Pancreatic fistula was recorded
in nine patients: two patients with grade A fistula and grade B
in seven patients (all conservatively managed). Other compli-
cations were registered in one patient: hemoperitoneum from
pancreatic stump imposing reintervention for hemostasis,
followed by pancreatic fistula.
The postoperative pancreatic fistula rate was higher in
the sPD group vs paPD group (42.85% vs 23.80%), but
there was no statistically significant difference between the
two groups (P=0.3264, NS).
Even if early morbidity rate in the sPD group is higher
than in the paPD group, there was no significant difference
between the two groups (P=0.7513, NS).
Complete data regarding early morbidity in the two
groups are shown in Table 2.
The mean length of hospitalization was 19.57 days
(±12.89) in the paPD group (range, 11 to 60 days), while in
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19.90 days (±12.87; range, 10 to 60 days). There was no
significant difference regarding the postoperative length of
hospitalization between the two groups (P=0.9336, NS).
The mortality rate in the whole 218 PD group was
3.21%. The nil mortality in the matched groups is probably
a matter of hazard. The morbidity rate in the whole 218 PD
group is 42.66%; the postoperative pancreatic fistula rate in
the whole group was 28.44% (grade A—8%, grade B—
85.5%, grade C—6.5%). The differences regarding early
postoperative morbidity, mainly pancreatic fistula, are not
statistically significantly different in the matched group
comparing to the whole 218 PD.
Patient survival
The mean overall survival rate in the paPD group was
19.9 months (±11.93) and, median survival time was
20.5 months. In the sPD group, the mean overall survival
rate was 20.8 months (±14.56), and median survival time
was 18.5 months. A detailed survival rate according to the
type of tumor in both groups is shown in Table 3.
There was no statistically significant difference between
the two groups regarding the overall survival rate (P=
0.6560, NS) and also no difference according to the tumor
type: ductal adenocarcinoma of the pancreas (P=0.9570,
NS), adenocarcinoma of the ampulla (P=0.3711, NS),
adenocarcinoma of the common bile duct (P=0.9176, NS).
Patient follow-up lasted until death or until cutoff date of
October 1, 2008. At the time of the last follow-up, 14
patients were still alive in the paPD group vs 12 patients in
the sPD group.
Discussion
PD is still considered a challenging operative technique
even nowadays, being indicated mostly for the malignan-
cies of the pancreatic head and periampullary region
(ampulla, distal common bile duct, duodenum) [1–4, 17].
Since the first descriptions of the PD technique by
Whipple and Kausch [8, 9], this operation has evolved over
the years and become a routine surgery in trained surgical
centers [1, 2, 4, 17, 18].
Many years, the mortality rate after PD was high (up to
25–35%), but in the present time, in experienced surgical
centers, it was recorded that there was a notable decrease
the mortality; nowadays, an accepted mortality rate after
PD must be below 5% [1, 2, 19, 20], although there are
high-caseload hospitals that report no postoperative mor-
tality [19]. Probably, a more realistic goal for modern
interdisciplinary approaches for PD in hospitals that
concentrate on pancreatic surgery is a mortality rate around
2% [17].
Despite the important decrease of mortality, morbidity
after PD still remains an important issue (up to 40–60%) [2,
20]. The morbidity is mainly correlated with hemorrhage
and remnant pancreatic stump “pathology”.
Many technical modification of the standard PD were
made, especially related to the pancreatic anastomosis
(considered Achilles’ heel of morbidity and mortality).
The technique of pancreatic anastomosis has been highly
standardized in individual centers [1, 17, 21], but there is
still no consensus about how to perform a safe pancreatic
anastomosis. Some prognostic factors for pancreatic anas-
tomosis failure have been defined: pancreatic duct diameter,
pancreatic tissue texture, surgical technique (traumatic, high
blood loss vs meticulous and tissue-sparing), associated
multivisceral resection (including vascular and extended
radical resections) [17, 22–25].
Regarding the type of operation (Whipple versus pylorus
preserving PD), it was demonstrated in 2008 by a meta-
analysis considering all randomized controlled trials com-
paring the two procedures that there is no evidence of
relevant differences in mortality, morbidity, and survival
between the two operations. However, it was noted that the
operating time and intraoperative blood loss were signifi-
cantly reduced in patients with pylorus-preserving PD [26].
Extended radical lymphadenectomy in PD has been also
demonstrated by a meta-analysis considering all random-
ized controlled trials comparing standard versus extended
lymphadenectomy that brings no benefit regarding overall
survival, and there may even be a trend toward increased
morbidity [27].
The paPD is a modified technique of sPD that was
initially proposed by Pessaux et al. starting from the
anatomical studies regarding the retroportal lamina. This
approach was proposed in order to overcome some
technical difficulties and to achieve an oncologically
acceptable lymph node dissection. The operative technique
consists mainly of early dissection of the SMA and the
posterior pancreatic capsule (“SMA first approach”). Thus,
some technical difficulties such as tumor infiltration of the
Table 2 Early postoperative morbidity in the two groups
Complication paPD sPD P value
Pancreatic fistula 5 9 0.3264, NS
Other complications 0.6628, NS
Hemoperitoneum 1 1
Upper digestive hemorrhage 1 –
Bronchopneumonia 1 –
Graft thrombosis 1 –
NS not significant
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of the SMA and SMV, presence of a replaced right hepatic
artery can be easier managed by posterior approach [10–
12]. Quite similar techniques were also described [28–31].
The paPD enable the surgeon to identify the non-
resectable cases during the early step of the operation, thus
avoiding the “point of no return” of sPD. In sPD, when
there is no clear preoperative imaging for tumor vascular
invasion, intraoperative assessment of local resectability (i.
e., SMA, PV, or SMV invasion) is made mainly after
transection of the pancreas. SMA tumor infiltration is
widely accepted as a contraindication for resection [17, 31,
32]. In sPD, SMA tumor infiltration is usually remarked
toward the end of resection process (after transection of the
pancreas), when there is “no point of return” and thus,
leading to a “margin-positive” resection (at least R1
resection or, not very seldom, even to an R2 resection).
From this point of view, we can clearly conclude that paPD
is better than sPD in early assessment of SMA tumor
infiltration, thus avoiding unnecessary resections.
Infiltration of the PV or SMV is encountered in many
patients, especially with pancreatic head tumors. Regarding
the assessment of tumor extension into the PV/SMV,
intaoperative ultrasound or even intraportal ultrasound can
be very useful [33]. En bloc PV/SMV resection is
nowadays considered a safe procedure with mortality and
morbidity rates quite similar to the sPD [1, 17, 31, 32, 34].
Using the paPD, the PV/SMV can be safely removed en
bloc by “no touch” resection. Depending on the location
and extension of tumor venous invasion, the proximal and
distal edges of the PV/SMV are looped, thus facilitating en
bloc resection. The key role of SMA to PV/SMV resection
in PD was also underlined by other experienced surgical
centers [28–31], even if there are some differences in the
operative technique, compared to paPD [10–12]. Neverthe-
less, dissection on the right and posterior part of the SMA
guides the surgeon through the critical part of the
procedure, enabling him to achieve a complete en bloc
tumor resection without interfering with tumor integrity
(“no touch resection”)[ 10–12, 28–31]. Regarding the
impact of PV/SMV resection on the long-term survival, it
seems that only in patients with “margin-negative” resec-
tions can be seen an improvement in long-term survival
[35, 36]. Direct dissection of the tumor from the PV/SMV
without using the “no touch” technique could transform a
potentially curative resection into a palliative one (by
increased risk for intraportal tumor dissemination).
The paPD can detect early a replaced right hepatic artery
originating from the SMA; in these cases, the artery must
clearly be identified and safeguarded [10–12, 35, 36]. In
cases of tumor invasion, resection and reconstruction of the
replaced right hepatic artery can be done using gastroduo-
denal artery stump [31].
The paPD, by carefully and complete dissection of
the retroportal lamina should lead to an increased
number of R0 resections, since it was demonstrated that
the medial and posterior margins are most commonly
involved [37]. However, in the present study, there was
no difference between the two groups regarding the
number of “margin-negative” (R0) resections in ductal
adenocarcinoma of the pancreas. This could also explain
the same results on long-term survival in the two groups.
Recent studies highlights the importance of pathological
reporting and suggests that tumor growth patterns and
thorough examination, but not surgical technique, deter-
mine R1 resection rates in pancreatic cancer; the same
study state that most pancreatic cancer resections are R1
resections (up to 76%) [37].
An interesting and significant difference in the present
matched study was related to operative time and intra-
operative blood loss. Thus, in the paPD group, both
operative time and intraoperative blood loss were signifi-
cantly lower than in the sPD group. The sPD, even in
experienced centers, is related to quite high blood loss
(mean ranging between 700 and 1,500 ml) [1, 38]. An
explanation for reduced blood loss in the paPD group could
be early ligation of inferior pancreaticoduodenal artery, thus
reducing the congestion into the pancreatic head (along
with gastroduodenal artery and portal vein tributaries
ligation). The impact of early ligation of inferior pancrea-
Table 3 Survival according to the type of tumor in the two groups
Type of tumor paPD sPD P value
Mean survival rate Median survival Mean survival rate Median survival
Ductal adenocarcinoma of the
pancreatic head
22 months (±15.57) 19 months 22 months (±16.50) 21 months 0.9570, NS
Adenocarcinoma of the ampulla 17.88 months (±11.67) 18 months 22.25 months (±10.40) 21 months 0.3711, NS
Adenocarcinoma of the distal
common bile duct
17.33 months (±14.74) 12 months 19.40 months (±13.93) 17 months 0.9176, NS
NS not significant
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described in other studies [39, 40]. A study of Horiguchi et
al. [39] describes a modified technique of sPD in which the
inferior pancreaticoduodenal artery and gastroduodenal
artery are ligated before ligating the corresponding afferent
veins of the pancreatic head, thus a significant lower
amount of bleeding was obtained compared to sPD, but
with no difference regarding the operative time. Another
study of Kawai et al. [40], using the preoperative computed
tomography image-assessed ligation of inferior pancreati-
coduodenal artery showed significant reduced blood loss,
correlated with a significant shorter operative time. Even if
intraoperative bleeding was reported to be a risk factor for
high morbidity after PD, in the present study, despite the
significant difference between the blood loss in the two
groups, the postoperativemorbidity rates werenot statistically
significantly different.
Conclusion
There is no significant difference between the paPD group
and sPD group regarding the overall survival rate and also
no difference according to the tumor type. Early postop-
erative mortality and morbidity rates in the two groups are
not significantly different. However, compared to sPD, the
paPD offers an early selection of patients during
the operation (in terms of local resectability, by assessing
the SMA infiltration), allows an optimal exposure of
arterial abnormalities (a replaced right hepatic artery from
the SMA) and better detect venous invasion. In cases with
PV/SMV invasion, paPD is particularly useful allowing a
“no-touch” r e s e c t i o nw i t hn oi n t r a p o r t a lt u m o rd i s s e m i n a -
tion and facilitates the vascular reconstruction. In addition,
the operative bleeding and time are lower in the paPD
group, probably due to early ligation of the inferior
pancreaticoduodenal artery and reduced congestion of
the pancreatic head.
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